What is the Difference Between Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy?

Left ventricular hypertrophy (LVH) and hypertrophic cardiomyopathy (HCM) are both conditions characterized by the thickening of the walls of the left ventricle, the heart's main pumping chamber. However, they have distinct causes and characteristics:

Left Ventricular Hypertrophy (LVH):

LVH is a thickening of the walls of the left ventricle, which can interfere with the heart's ability to pump blood effectively.
The most common cause of LVH is high blood pressure (hypertension), which makes the heart work harder to pump blood, leading to the thickening of the left ventricle walls.
LVH can also occur due to other conditions that make the heart work harder, such as aortic stenosis or pregnancy.
In some cases, intense athletic training can lead to an increase in the size and thickness of the left ventricle, but the heart function remains normal.

Hypertrophic Cardiomyopathy (HCM):

HCM is defined as unexplained left ventricular hypertrophy in the absence of precipitating factors such as hypertension or aortic stenosis.
HCM is caused by mutations in sarcomere genes, which lead to the thickening of the heart muscle.
The condition is not reversible, unlike LVH in patients with hypertension.

Differentiating between LVH and HCM can be challenging, especially in cases where physiological LVH is present, such as in elite athletes. However, distinguishing between the two is crucial for appropriate management and treatment, as misdiagnosis can lead to unnecessary interventions or missed opportunities for treatment.

On this page

What is the Difference Between Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy?

Comparative Table: Left Ventricular Hypertrophy vs Hypertrophic Cardiomyopathy

Left Ventricular Hypertrophy (LVH) and Hypertrophic Cardiomyopathy (HCM) are two associated heart conditions that involve the thickening of the heart muscles. Here is a table comparing the differences between the two:

Feature	Left Ventricular Hypertrophy (LVH)	Hypertrophic Cardiomyopathy (HCM)
Definition	Thickening of the walls of the heart	Thickening of the heart muscles, especially in the septum between the two bottom chambers
Causes	High blood pressure, narrowing of the aortic valve, intensive athletic training	Changes in the sarcomere genes
Etiologies	Hypertensive heart disease (HHD), light-chain cardiac amyloidosis (ALCA)	Mutations in sarcomere proteins, such as myosin, actin, troponin T or C, α-tropomyosin, myophosphorylase, myoglobin, and desmin
Diagnosis	Physical examination, blood tests, electrocardiograms	Physical examination, blood tests, electrocardiograms
Complications	Chest pain, fainting	Chest pain, fainting, heart failure, arrhythmias, sudden cardiac death
Treatment	Depends on the underlying cause, may include medication, lifestyle changes, or surgery	Depends on the severity and cause, may include medication, lifestyle changes, surgery, or implantable cardioverter-defibrillator

Both conditions may cause similar symptoms and complications, and they can be diagnosed through physical examination, blood tests, and electrocardiograms. However, the causes and underlying mechanisms of the two conditions differ, with LVH being caused by factors such as high blood pressure and athletic training, while HCM is caused by genetic mutations affecting the sarcomere proteins.

Guilherme Mazui

Guilherme Mazui is graduated in journalism from the Federal University of Minas Gerais (UFMG) and a master's degree in Communication from the University of São Paulo (USP). In addition, he has experience in advertising writing and has worked as a content editor in several companies.